In the following video, Motley Fool health-care analyst David Williamson takes investors through what to expect from Bristol-Myers Squibb's (BMY 1.30%) upcoming earnings report and the important things to watch from this company moving forward.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.